Alphahelix Molecular Diagnostics AB
0
0
+SEK0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-10.94%Profit Margin
Unprofitable32.36MRevenue
-3.54MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
Show More
CEO
ISIN
SE0000885501
WKN
000A0MRZZ
Listings
0 Comments
Share your thoughts
FAQs
What is Alphahelix Molecular Diagnostics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Alphahelix Molecular Diagnostics AB stocks are traded under the ticker ALPH.ST.
What is Alphahelix Molecular Diagnostics AB revenue for the last year?▼
Alphahelix Molecular Diagnostics AB revenue for the last year amounts to 32.36M SEK.
What is Alphahelix Molecular Diagnostics AB net income for the last year?▼
ALPH.ST net income for the last year is -3.54M SEK.
In which sector is Alphahelix Molecular Diagnostics AB located?▼
Alphahelix Molecular Diagnostics AB operates in the Other sector.
When did Alphahelix Molecular Diagnostics AB complete a stock split?▼
Alphahelix Molecular Diagnostics AB has not had any recent stock splits.